Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation.
Teraoka
S
S
Kidney Center, Tokyo Women's Medical College, Japan.
Babazono
T
T
Koike
T
T
Abe
M
M
Kimikawa
M
M
Shinkai
M
M
Haruguchi
H
H
Hirotani
S
S
Kitajima
K
K
Akamatsu
M
M
D000328:Adult; D000681:Amylases / Q000652:urine; D015415:Biomarkers / Q000652:urine; D001786:Blood Glucose / Q000378:metabolism; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000032:analysis; D006084:Graft Rejection / Q000175:diagnosis / Q000188:drug therapy*; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D012008:Recurrence; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors; D014556:Urine / Q000166:cytology
D000681:Amylases; D015415:Biomarkers; D001786:Blood Glucose; D003404:Creatinine; D016572:Cyclosporine; D006442:Glycated Hemoglobin; D007166:Immunosuppressive Agents; D016559:Tacrolimus